1. Home
  2. IRON vs CLMT Comparison

IRON vs CLMT Comparison

Compare IRON & CLMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

N/A

Current Price

$63.61

Market Cap

3.1B

Sector

Health Care

ML Signal

N/A

Logo Calumet Specialty Products Partners L.P.

CLMT

Calumet Specialty Products Partners L.P.

N/A

Current Price

$52.65

Market Cap

3.4B

Sector

Energy

ML Signal

N/A

Company Overview

Basic Information
Metric
IRON
CLMT
Founded
2017
1916
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
3.4B
IPO Year
2020
2024

Fundamental Metrics

Financial Performance
Metric
IRON
CLMT
Price
$63.61
$52.65
Analyst Decision
Strong Buy
Buy
Analyst Count
13
6
Target Price
★ $103.17
$53.40
AVG Volume (30 Days)
444.2K
★ 1.1M
Earning Date
11-05-2026
11-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 85.39
EPS
★ N/A
N/A
Revenue
N/A
★ $4,137,100,000.00
Revenue This Year
N/A
$19.21
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$40.00
$17.42
52 Week High
$99.50
$59.87

Technical Indicators

Market Signals
Indicator
IRON
CLMT
Relative Strength Index (RSI) 31.11 48.73
Support Level $65.04 $39.44
Resistance Level $72.68 $59.87
Average True Range (ATR) 2.42 2.35
MACD -0.21 -0.93
Stochastic Oscillator 22.75 16.64

Price Performance

Historical Comparison
IRON
CLMT

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

About CLMT Calumet Specialty Products Partners L.P.

Calumet Inc is a producer of specialty products, including base oils, specialty oils, solvents, esters, and waxes, as well as a variety of fuel and fuel-related products, including asphalt and heavy fuel oils. The company manufactures, formulates, and markets a variety of specialty branded products to customers in various consumer-facing and industrial markets. Its segments include: Specialty Products and Solutions; Montana/Renewables; Performance Brands; and Corporate. The company generates maximum revenue from Fuels, asphalt and other by-products.

Share on Social Networks: